Agenda
All times are Pacific Time
  • MAR 19, 2014 06:00 AM PDT
    Speaker: Rafael Yuste, MD, PhD
  • MAR 19, 2014 07:00 AM PDT
    Speaker: Benjamin Greenberg, MD
  • MAR 19, 2014 07:00 AM PDT
    Speaker: Ahmad Salehi, MD, PhD
  • MAR 19, 2014 08:00 AM PDT
    Speaker: Emery N. Brown, MD, PhD, William Newsome, PhD, Justin Sanchez, PhD, Terrence J Sejnowski, PhD
  • MAR 19, 2014 09:00 AM PDT
    Speaker: Kristen Harris, PhD
  • MAR 19, 2014 09:00 AM PDT
    Brain Computer Interfaces: Neurotech in the Future of Neuroscience
    Speaker: Lana Morrow, PhD
  • MAR 19, 2014 09:00 AM PDT
    Remyelinating the adult central nervous system: Repairing injury in MS
    Speaker: Ari Green, MD
  • MAR 19, 2014 10:00 AM PDT
    Speaker: Peter Glick, PhD
  • MAR 19, 2014 10:00 AM PDT
    Speaker: Pierre-Antoine Gourraud, PhD, MPH
  • MAR 19, 2014 10:00 AM PDT
    Speaker: Michael Salter, MD, PhD, FRSC
  • MAR 19, 2014 12:00 PM PDT
    Speaker: Susan Catalano, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAR 19, 2014 12:00 PM PDT
    Src Regulation of Lamellipodia, Filopodia, and Substrate-Cytoskeletal Coupling in Neuronal Growth Cones
    Speaker: Daniel Suter, PhD
  • MAR 19, 2014 01:00 PM PDT
    Speaker: Radosveta Koldamova, MD, PhD
  • MAR 19, 2014 01:00 PM PDT
    Speaker: Stephanie Willerth, PhD
  • MAR 20, 2014 06:00 AM PDT
    Speaker: Scott W. Emmons, PhD
  • MAR 20, 2014 07:00 AM PDT
    Speaker: Margaret Sutherland, PhD
    SEE ABSTRACT | Continuing Education: CE
  • MAR 20, 2014 07:00 AM PDT
    Speaker: Edward S. Boyden, PhD
  • MAR 20, 2014 08:00 AM PDT
    Speaker: Prashanthi Vemuri, PhD
  • MAR 20, 2014 09:00 AM PDT
    Speaker: Story Landis, PhD, Thomas R. Insel, MD, Justin Sanchez, PhD, John C. Wingfield
  • MAR 20, 2014 10:00 AM PDT
    Speaker: Ralph-Axel Mueller, PhD
  • MAR 20, 2014 10:00 AM PDT
    Speaker: Lana Morrow, PhD
  • MAR 20, 2014 10:00 AM PDT
    Speaker: David N. Kennedy, PhD
  • MAR 20, 2014 11:00 AM PDT
    Speaker: Michael Weiner, MD
  • MAR 20, 2014 12:00 PM PDT
    Speaker: Ulrich Hengst, PhD
  • MAR 20, 2014 12:00 PM PDT
    Speaker: Alison Goate, D.Phil
  • MAR 20, 2014 12:00 PM PDT
    Speaker: Stephen Scott, PhD
  • MAR 20, 2014 01:00 PM PDT
    Speaker: Elvire Vaucher, PhD
  • MAR 20, 2014 01:00 PM PDT
    Speaker: Orly Lazarov, PhD
  • MAR 20, 2014 01:00 PM PDT
    The role of high throughput sequencing in the research and diagnosis of neurodegenerative disorders
    Speaker: Peter L Nagy, MD, PhD
  • MAR 20, 2014 02:00 PM PDT
    Speaker: Evan W. Snyder, M.D., Ph.D., F.A.A.P
  • MAR 20, 2014 02:00 PM PDT
    Disinhibition Drives Rapid Movement and Associative Motor Memory Formation in the Cerebellum
    Speaker: Paul Mathews, PhD
  • MAR 20, 2014 02:00 PM PDT
    Genetics of Parkinsons disease
    Speaker: Katerina Venderova, PhD
  • BRAIN Initiative
  • MAR 19, 2014 08:00 AM PDT
    Speaker: Emery N. Brown, MD, PhD, William Newsome, PhD, Justin Sanchez, PhD, Terrence J Sejnowski, PhD
  • MAR 19, 2014 09:00 AM PDT
    Brain Computer Interfaces: Neurotech in the Future of Neuroscience
    Speaker: Lana Morrow, PhD
  • Neurological Diseases from Lab to Clinic
  • MAR 20, 2014 07:00 AM PDT
    Speaker: Margaret Sutherland, PhD
    SEE ABSTRACT | Continuing Education: CE
  • Emerging Therapies, Technologies and Methods
  • MAR 20, 2014 10:00 AM PDT
    Speaker: Lana Morrow, PhD
  • Nervous System Development & Function
  • MAR 20, 2014 02:00 PM PDT
    Disinhibition Drives Rapid Movement and Associative Motor Memory Formation in the Cerebellum
    Speaker: Paul Mathews, PhD
  • Behavioral and Cognitive Neuroscience
  • MAR 19, 2014 10:00 AM PDT
    Speaker: Peter Glick, PhD
  • MAR 20, 2014 08:00 AM PDT
    Speaker: Prashanthi Vemuri, PhD
  • MAR 20, 2014 10:00 AM PDT
    Speaker: David N. Kennedy, PhD
  • Neurological Dysfunction from Genes to Human Disease
  • MAR 19, 2014 10:00 AM PDT
    Speaker: Michael Salter, MD, PhD, FRSC
  • MAR 20, 2014 10:00 AM PDT
    Speaker: Ralph-Axel Mueller, PhD
  • MAR 20, 2014 12:00 PM PDT
    Speaker: Alison Goate, D.Phil
  • MAR 20, 2014 01:00 PM PDT
    The role of high throughput sequencing in the research and diagnosis of neurodegenerative disorders
    Speaker: Peter L Nagy, MD, PhD
  • MAR 20, 2014 02:00 PM PDT
    Genetics of Parkinsons disease
    Speaker: Katerina Venderova, PhD
  • Keynote
  • MAR 20, 2014 11:00 AM PDT
    Speaker: Michael Weiner, MD
MAR 19 - 20 2014
Neuroscience
1180 41 115470

BioConference Live makes it easier and more cost-effective for the neuroscience research community to come together online through live video webcasts and real-time networking. BioConference Live attendees learn new concepts, tools and techniques that they can apply to research and diagnosis. BioConference Live requires no travel or time away from the lab or hospital, yet delivers all the benefits of a physical conference. Attendees can earn free CME and CE Credits.

Learn about recent investments and the scientific foci of the BRAIN Initiative through a panel discussion with key leaders from different scientific and funding regulatory agencies. The BRAIN Initiative is part of a new Presidential focus aimed at revolutionizing our understanding of the human brain.

Other topics will include: A panel discussion on Multiple Sclerosis, Neurologic Function and Dysfunction, Nervous System Development & Function, Neurologic Dysfunction from Molecular Mechanism to Human Diseases, Genetics of Neurologic Diseases and Epigenetic Regulation, Neurologic Diseases from Lab to Clinic including: Alzheimer?s, Parkinson?s, Huntington?s disease, ALS, traumatic brain & spinal cord injury, Epilepsy, neuropsychiatric disorders, Emerging Therapies including: immunomodulation, stem cells, non-coding RNA, neuroengineering, neurorobotics, myelin repair, combinatorial therapies, Imaging Technologies (in vitro and in vivo), Power of Methods including: diagnostic tests, biomarkers, tools to detect therapeutic responses, and Behavioral and Cognitive Neuroscience.

This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in neuroscience. This conference offers an amazing opportunity as it is free to participants, and there will be no out-of-pocket expenses for travel. However, participants will still benefit from interacting with a global community of like-minded colleagues, without leaving the comfort of their office or home.


Conference participants will be able to
 

  • Attend interactive live streaming video sessions
  • Have their questions answered in real-time by industry experts
  • Chat live with peers and speakers
  • Browse a virtual exhibit floor for solution providers


No crowded airports, delayed flights or expensive hotel rooms, but still the look and feel of a first-rate conference with world renowned experts. Participants also benefit from the fact that experts and vendors are more accessible, no more waiting in line to speak to someone. Think it is too good to be true? Checkout the venue and become a believer.


Speakers:
  • NIH Director's Pioneer Awardee, Professor of Biological Sciences and Neuroscience, Columbia University, Co-director of the Kavli Foundations Institute for Neural Circuitry
  • Story Landis, PhD Director, National Institute for Neurological Disorders and Stroke (NINDS) Thomas R. Insel, MD Director, National Institute of Mental Health (NIMH) Justin Sanchez, PhD
  • Story Landis, PhD Director, National Institute for Neurological Disorders and Stroke (NINDS) Thomas R. Insel, MD Director, National Institute of Mental Health (NIMH) Justin Sanchez, PhD
  • Principle Investigator of the Alzheimer's Disease, Neuroimaging Initiative, Professor in Residence, Medicine, Psychiatry, and Neurology, University of California, San Francisco
  • Assistant Professor of Pathology and Cell Biology , Taub Institute for Research on Alzheimers Disease, Columbia University
  • Full professor Ecole doptomtrie, Universit de Montral, Qubec, Canada
  • Postdoctoral research scientist, UCLA
  • Director of the Brain Development Imaging Lab, Professor of Psychology, San Diego State University
  • Samuel & Mae S. Ludwig Professor of Genetics in Psychiatry, Professor of Neurology, Dept. of Psychiatry, Washington University School of Medicine
  • Director of Next-Gen Sequencing Laboratory Laboratory of Personalized Genomic Medicine, Associate Professor, Columbia University
  • Assistant Professor Department of Physiology and Pharmacology, University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences
  • Program Director in the Neurodegeneration Cluster, NIH/NINDS
  • Professor Department of Biomedical and Molecular Sciences, Queens University School of Medicine
  • Associate Professor of Anatomy and Cell Biology, University of Illinois College of Medicine
  • Founder and CEO, Think Interfaces, Inc.
  • Director Stem Cell Research Center & Core Facility, Professor, Sanford-Burnham Medical Research Inst, Faculty Physician, Department of Pediatrics, University of California, San Diego
  • Assistant Professor at the Aging and Dementia Imaging Laboratory, Department of Radiology, Mayo Clinic
  • Professor of Anatomy and Neurobiology, Washington University School of Medicine
  • Joint Professor at MIT, Synthetic Neurobiology Research Group, AT&T Career Development Associate Professor, MIT
  • Siegfried Ullmann Professor of Genetics, Professor of Neuroscience, Albert Einstein College of Medicine
  • Emery N. Brown, MD, PhD Warren M. Zapol Prof. of Anaesthesia Harvard Medical School, Prof. of Computational Neuroscience MIT, Director, Neuroscience Statistics Research Laboratory, Anestheti
  • Emery N. Brown, MD, PhD Warren M. Zapol Prof. of Anaesthesia Harvard Medical School, Prof. of Computational Neuroscience MIT, Director, Neuroscience Statistics Research Laboratory, Anestheti
  • Founder and CEO, Think Interfaces, Inc.
  • Distinguished Professor of Neuroscience, Professor of Psychiatry and Psychology Department of Neuroscience, University of Pittsburgh
  • Associate Chair, Department of Neuroscience, Professor of Neuroscience , Fellow Center for Learning and Memory, University of Texas at Austin
  • Associate Professor, Department of Biological Sciences, Purdue University
  • Head and Senior Scientist of Neurosciences & Mental Health, Associate Chief of Science Strategy Research, Sick Kids Research Institute
  • Associate Professor Cain Denius Scholar in Mobility Disorders, Department of Neurology & Neurotherapeutics, Pediatrics, UT Southwestern Medical Center
  • Director of UCSF Neurodiagnostics Center, Director of UCSF Multiple Sclerosis Center, Rachleff Endowed Professor, Associate Professor of Neurology and Opthalmology, UCSF School of Medicine
  • Assistant Adjunct Professor of Neurology, University of California, San Francisco
  • Founder and Chief Science Officer, Cognition Therapeutics, Inc.
  • Associate Professor at the Department of Environmental & Occupational Health, University of Pittsburgh
  • Clinical Associate Professor Department of Psychiatry & Behavioral Sciences, Stanford Medical School
  • Michael Hooker Distinguished Professor, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy
  • Assistant Professor, University of Victoria Engineering, Canada
  • Henry Merritt Wriston Professor of the Social Sciences, Professor of Psychology, Lawrence University
  • Professor, Univ of Massachusettes Medical School, Department of Psychiatry, Director of the Division of Neuroinformatics at the Child and Adolescent Neurodevelopment Initiative

Show Resources
Speakers

  • Rafael Yuste, MD, PhD
    NIH Director's Pioneer Awardee, Professor of Biological Sciences and Neuroscience, Columbia University, Co-director of the Kavli Foundations Institute for Neural Circuitry
    Biography
      Rafael Yuste is an HHMI Investigator, Professor of Biological Sciences and Neuroscience at Columbia University and Co-director of the Kavli Foundations Institute for Neural Circuitry. He obtained his M.D. at the Universidad Autonoma in Madrid. After a brief period in Brenners laboratory in Cambridge, he did his Ph.D work with Katz and Wiesel at Rockefeller University and postdoctoral research with Tank and Denk at Bell Labs. Dr. Yuste has pioneered the application of imaging techniques in neuroscience, such as calcium imaging of neuronal circuits, two-photon imaging, photostimulation using caged compounds and holographic spatial light modulation microscopy. These technical developments have resulted in several patents, two of which are commercially licensed. Yuste has obtained many awards for his work, including New York City Mayors and the Society for Neurosciences Young Investigator Awards. Finally, he has recently been involved in launching the Brain Activity Map Project, a large-scale international effort to record and manipulate the activity of every neuron in brain circuits, a role highlighted by Nature who named Yuste One of the 5 scientists to watch in 2013. Dr. Yuste and his laboratory are pursuing a reverse engineering strategy to understand the function of the cortical microcircuit, a basic element of cortex architecture.
    • Story Landis, PhD, Thomas R. Insel, MD, Justin Sanchez, PhD, John C. Wingfield
      Story Landis, PhD Director, National Institute for Neurological Disorders and Stroke (NINDS) Thomas R. Insel, MD Director, National Institute of Mental Health (NIMH) Justin Sanchez, PhD
      Biography
        Story Landis, Ph.D. has been Director of the National Institute for Neurological Disorders and Stroke (NINDS) since 2003. A native of New England, Dr. Landis received her undergraduate degree from Wellesley College (1967) and her Ph.D. from Harvard University (1973). After postdoctoral work at Harvard University, she served on the faculty of the Department of Neurobiology there. In 1985, she joined the faculty of Case Western Reserve University School of Medicine, where she created the Department of Neurosciences which, under her leadership, achieved an international reputation for excellence. Throughout her research career, Dr. Landis has made fundamental contributions to the understanding of nervous system development. She has garnered many honors, is an elected fellow of the Institute of Medicine, the Academy of Arts and Sciences, the American Association for the Advancement of Science and the American Neurological Association, and in 2002 was elected President of the Society for Neuroscience. Dr. Landis joined the NINDS in 1995 as Scientific Director and worked to re-engineer the Institute's intramural research programs. Between 1999 and 2000, she led the movement, together with the NIMH Scientific Director, to bring a sense of unity and common purpose to 200 neuroscience laboratories from eleven different NIH Institutes. As NINDS Director, Dr. Landis oversees an annual budget of $1.6 billion that supports research by investigators in public and private institutions across the country, as well as by scientists working in its intramural program. Together with NIMH and NIA directors, she co-chairs the NIH Blueprint for Neuroscience Research, a roadmap-like effort to support trans-NIH activities in the brain sciences. In 2007, Dr. Landis was named Chair of the NIH Stem Cell Task Force. Thomas R. Insel, M.D., is Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health charged with generating the knowledge needed to understand, treat, and prevent mental disorders. His tenure at NIMH has been distinguished by groundbreaking findings in the areas of practical clinical trials, autism research, and the role of genetics in mental illnesses. Prior to his appointment as NIMH Director in the Fall 2002, Dr. Insel was Professor of Psychiatry at Emory University. There, he was founding director of the Center for Behavioral Neuroscience, one of the largest science and technology centers funded by the National Science Foundation and, concurrently, director of an NIH-funded Center for Autism Research. From 1994 to 1999, he was Director of the Yerkes Regional Primate Research Center in Atlanta. While at Emory, Dr. Insel continued the line of research he had initiated at NIMH studying the neurobiology of complex social behaviors. He has published over 250 scientific articles and four books, including the Neurobiology of Parental Care (with Michael Numan) in 2003. Dr. Insel has served on numerous academic, scientific, and professional committees and boards. He is a member of the Institute of Medicine, a fellow of the American College of Neuropsychopharmacology, and is a recipient of several awards including the Outstanding Service Award from the U.S. Public Health Service. Dr. Insel graduated from the combined B.A.-M.D. program at Boston University in 1974. He did his internship at Berkshire Medical Center, Pittsfield, Massachusetts, and his residency at the Langley Porter Neuropsychiatric Institute at the University of California, San Francisco. Dr. Justin Sanchez joined DSO as a program manager in 2013. At DARPA, Dr. Sanchez will explore neurotechnology, brain science and systems neurobiology. Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourettes syndrome and Obsessive-Compulsive Disorder. Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system. He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoDs Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology. Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida. Dr. John C. Wingfield is the assistant director for Biological Sciences (BIO) at the National Science Foundation (NSF). Wingfield's research has covered a wide spectrum of biology from molecular and organismal to environmental and ecological scales. He joined NSF as division director for Integrative Organismal Systems in September 2010 from the University of California, Davis. Wingfield is a distinguished scientist and active researcher with a strong record of scholarly scientific publication and leadership experience. His research focuses on neural pathways for environmental signals affecting seasonality in birds and their mechanisms of coping with environmental stress. His research also interfaces with how animals deal with global climate change, endocrine disruption and conservation biology. Wingfield has delivered numerous invited lectures, served on several editorial boards, and held positions as associate editor and/or editor-in-chief for major journals in his fields. He has received many honors from his peers and served as president of the Society for Integrative and Comparative Biology. He also has an extensive record of service to NSF and scientific advisory boards. Prior to joining NSF in 2010, Wingfield was the chair for the department of zoology at the University of Washington from 1999 to 2003, and has held an Endowed Chair in Physiology at UC-Davis since 2007. Wingfield received his Bachelor of Science degree in zoology from the University of Sheffield and a Ph.D. in zoology and comparative endocrinology from the University College of North Wales.
      • Story Landis, PhD, Thomas R. Insel, MD, Justin Sanchez, PhD, John C. Wingfield
        Story Landis, PhD Director, National Institute for Neurological Disorders and Stroke (NINDS) Thomas R. Insel, MD Director, National Institute of Mental Health (NIMH) Justin Sanchez, PhD
        Biography
          Story Landis, Ph.D. has been Director of the National Institute for Neurological Disorders and Stroke (NINDS) since 2003. A native of New England, Dr. Landis received her undergraduate degree from Wellesley College (1967) and her Ph.D. from Harvard University (1973). After postdoctoral work at Harvard University, she served on the faculty of the Department of Neurobiology there. In 1985, she joined the faculty of Case Western Reserve University School of Medicine, where she created the Department of Neurosciences which, under her leadership, achieved an international reputation for excellence. Throughout her research career, Dr. Landis has made fundamental contributions to the understanding of nervous system development. She has garnered many honors, is an elected fellow of the Institute of Medicine, the Academy of Arts and Sciences, the American Association for the Advancement of Science and the American Neurological Association, and in 2002 was elected President of the Society for Neuroscience. Dr. Landis joined the NINDS in 1995 as Scientific Director and worked to re-engineer the Institute's intramural research programs. Between 1999 and 2000, she led the movement, together with the NIMH Scientific Director, to bring a sense of unity and common purpose to 200 neuroscience laboratories from eleven different NIH Institutes. As NINDS Director, Dr. Landis oversees an annual budget of $1.6 billion that supports research by investigators in public and private institutions across the country, as well as by scientists working in its intramural program. Together with NIMH and NIA directors, she co-chairs the NIH Blueprint for Neuroscience Research, a roadmap-like effort to support trans-NIH activities in the brain sciences. In 2007, Dr. Landis was named Chair of the NIH Stem Cell Task Force. Thomas R. Insel, M.D., is Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health charged with generating the knowledge needed to understand, treat, and prevent mental disorders. His tenure at NIMH has been distinguished by groundbreaking findings in the areas of practical clinical trials, autism research, and the role of genetics in mental illnesses. Prior to his appointment as NIMH Director in the Fall 2002, Dr. Insel was Professor of Psychiatry at Emory University. There, he was founding director of the Center for Behavioral Neuroscience, one of the largest science and technology centers funded by the National Science Foundation and, concurrently, director of an NIH-funded Center for Autism Research. From 1994 to 1999, he was Director of the Yerkes Regional Primate Research Center in Atlanta. While at Emory, Dr. Insel continued the line of research he had initiated at NIMH studying the neurobiology of complex social behaviors. He has published over 250 scientific articles and four books, including the Neurobiology of Parental Care (with Michael Numan) in 2003. Dr. Insel has served on numerous academic, scientific, and professional committees and boards. He is a member of the Institute of Medicine, a fellow of the American College of Neuropsychopharmacology, and is a recipient of several awards including the Outstanding Service Award from the U.S. Public Health Service. Dr. Insel graduated from the combined B.A.-M.D. program at Boston University in 1974. He did his internship at Berkshire Medical Center, Pittsfield, Massachusetts, and his residency at the Langley Porter Neuropsychiatric Institute at the University of California, San Francisco. Dr. Justin Sanchez joined DSO as a program manager in 2013. At DARPA, Dr. Sanchez will explore neurotechnology, brain science and systems neurobiology. Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourettes syndrome and Obsessive-Compulsive Disorder. Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system. He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoDs Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology. Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida. Dr. John C. Wingfield is the assistant director for Biological Sciences (BIO) at the National Science Foundation (NSF). Wingfield's research has covered a wide spectrum of biology from molecular and organismal to environmental and ecological scales. He joined NSF as division director for Integrative Organismal Systems in September 2010 from the University of California, Davis. Wingfield is a distinguished scientist and active researcher with a strong record of scholarly scientific publication and leadership experience. His research focuses on neural pathways for environmental signals affecting seasonality in birds and their mechanisms of coping with environmental stress. His research also interfaces with how animals deal with global climate change, endocrine disruption and conservation biology. Wingfield has delivered numerous invited lectures, served on several editorial boards, and held positions as associate editor and/or editor-in-chief for major journals in his fields. He has received many honors from his peers and served as president of the Society for Integrative and Comparative Biology. He also has an extensive record of service to NSF and scientific advisory boards. Prior to joining NSF in 2010, Wingfield was the chair for the department of zoology at the University of Washington from 1999 to 2003, and has held an Endowed Chair in Physiology at UC-Davis since 2007. Wingfield received his Bachelor of Science degree in zoology from the University of Sheffield and a Ph.D. in zoology and comparative endocrinology from the University College of North Wales.
        • Michael Weiner, MD
          Principle Investigator of the Alzheimer's Disease, Neuroimaging Initiative, Professor in Residence, Medicine, Psychiatry, and Neurology, University of California, San Francisco
          Biography
            Michael Weiner, MD, is a Professor in Residence in Radiology and Biomedical Engineering, Medicine, Psychiatry, and Neurology at the University of California, San Francisco. He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which is the largest observational study in the world concerning Alzheimer's Disease. He is the former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center. After graduating from the Johns Hopkins University in 1961, He obtained his M.D, from SUNY Upstate Medical Center in Syracuse, New York in 1965, and he completed his internship and residency in Medicine from Mt. Sinai Hospital in 1967. From 1967-1968, Dr. Weiner completed a residency and clinical fellowship in Metabolism from Yale-New Haven Medical Center. In 1970, he completed a research fellowship in Nephrology from Yale University School of Medicine and a research fellowship in Biochemistry from the University of Wisconsin Institute for Enzyme Research in 1972, followed by a joint appointment in the Department of Medicine, Renal Section from the University of Wisconsin Institute in 1972. In 1974 he became an Assistant Professor of Medicine (Nephrology) at Stanford University, and in 1980 he became an Associate Professor of Medicine (Nephrology) at UCSF. In 1983, he established the Magnetic Resonance Unit at the San Francisco VA Medical Center, which became the Center for Imaging of Neurodegenerative Diseases in 2000. In 1990, he became a Professor of Radiology, Medicine, Psychiatry and Neurology at UCSF. During the past 25 years he has worked to develop and optimized the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimers disease and other neurodegenerative disorders. Also, Dr. Weiners research focuses on monitoring effects of treatment to slow progressions in Alzheimers disease, and detecting Alzheimers disease early in patients who are not demented, but risk subsequent development of dementia. He is the Principle Investigator of the Alzheimers Disease Neuroimaging Initiative which has enrolled over 1500 subjects (including controls, MCI, and AD) at 68 sites across the USA and Canada for cognitive testing, MRI, PET, and lumbar puncture. He has also launched The Brain Initiative, which is a web-based registry for recruiting, screening, and longitudinally monitoring subjects for neuroscience studies of all types. Dr. Weiner has 649 published articles and he has written 70 book chapters.
          • Ulrich Hengst, PhD
            Assistant Professor of Pathology and Cell Biology , Taub Institute for Research on Alzheimers Disease, Columbia University
            Biography
              Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the University of Basel. For his postdoctoral training, Dr. Hengst joined the laboratory of Samie R. Jaffrey, MD, PhD at the Weill Cornell Medical College in New York, NY. In Dr. Jaffreys group, he investigated the role of axonally localized mRNAs for axonal development leading to the identification of the first examples of specific mRNAs that are translated in axons in response to extracellular signaling molecules and that mediate growth cone collapse and axon elongation, respectively. In 2009, Dr. Hengst joined the Department of Pathology and Cell Biology and the Taub Institute for Research on Alzheimers Disease and the Aging Brain at Columbia University Medical Center in New York, NY, as an Assistant Professor. He has successfully established new research projects addressing the role of local protein synthesis in Alzheimers disease and neurodevelopment.
            • Elvire Vaucher, PhD
              Full professor Ecole doptomtrie, Universit de Montral, Qubec, Canada
              Biography
                Dr Vaucher obtained her PhD Neurosciences at Universit Paris VI. CNRS UA 641, Paris / Institut Neurologique de Montral, Qubec. She has completed two post-doctoral formations in the field of the involvement of the cholnergic deficit in Alzheimer's disease. The aim of her research group is to determine the role of neurotransmitters in the visual processing, especially the role of neuromodulators such as acetylcholine in modifying the cortical representation of specific stimuli and the cortical plasticity. This project will extend the basic knowledge of how the visual stimuli are integrated by the cortical networks (including learning, memory and attentional processes) and will permit to use pharmacological agents as cognitive and/or sensory enhancers to facilitate sight recovery and cortical plasticity.
              • Paul Mathews, PhD
                Postdoctoral research scientist, UCLA
                Biography
                  Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace Golding. Dr. Mathews work focused on understanding how the biophysical properties of specific voltage-gated ion channels in an auditory brainstem nuclei contribute to their capacity to make sub-millisecond computations necessary for low frequency sound localization. For the past several years Dr. Mathews has been working at UCLA under the mentorship of Dr. Tom Otis where he is currently working to uncover the cerebellar circuit mechanisms that underlie motor learning and memory. To do this Dr. Mathews is utilizing a multifaceted approach that includes both in vitro and in vivo electrophysiology, optogenetics, advanced optics, histology, and behavioral manipulations to make links between cerebellar circuit activity and motor output in rodent models. He is currently on the job market looking for a tenured track assistant professor position. <br />
                • Ralph-Axel Mueller, PhD
                  Director of the Brain Development Imaging Lab, Professor of Psychology, San Diego State University
                  Biography
                    Dr. Ralph-Axel Mueller is Professor of Psychology at San Diego State University (San Diego, CA). He received his Ph.D. from the Johann-Wolfgang-Goethe University of Frankfurt (Germany) and received postdoctoral training with Dr. Harry Chugani at Childrens Hospital of Michigan. Over the past twenty years, Dr. Mueller has applied functional and anatomical imaging techniques to the study of brain development in typical children and adolescents, as well as those with developmental disorders. While his early work focused on the implementation of positron emission tomography in children with epilepsy and tumors in preparation for neurosurgery and on the investigation of lesion-induced neuroplasticity, work in the past 15 years has been dedicated to magnetic resonance imaging in autism. His group was among the first to use functional MRI and subsequently functional connectivity MRI in the study of brain network abnormalities in autism spectrum disorders. More recently, work in his laboratory has expanded to include other imaging techniques, such as diffusion tensor imaging (for the study of anatomical connectivity), as well as anatomical brain volumetrics and magnetic resonance spectroscopy. Dr. Mueller laboratory (www.sci.sdsu.edu/~amueller/web/BDIL) has been continuously funded by grants from the National Institutes of Health (NINDS, NIDCD, NIMH) and other agencies since 2001.
                  • Alison Goate, D.Phil
                    Samuel &amp; Mae S. Ludwig Professor of Genetics in Psychiatry, Professor of Neurology, Dept. of Psychiatry, Washington University School of Medicine
                    Biography
                      Alison M Goate is the Samuel & Mae S Ludwig Professor of Genetics in Psychiatry, Professor of Genetics and Professor of Neurology at Washington University School of Medicine in St Louis (MO, USA). Dr Goate studied for her undergraduate degree in biochemistry at the University of Bristol (UK) and received her graduate training at Oxford University (UK). She performed postdoctoral studies with Professor Theodore Puck, Professor Louis Lim and Dr John Hardy before receiving a Royal Society University Research Fellowship to support her independent research program at St Mary's Hospital Medical School in London. In 1991, Dr Goate and colleagues reported the first mutation linked to an inherited form of Alzheimer's disease, in the amyloid precursor protein (APP) gene on chromosome 21. The mutation was found to be linked to inherited cases of early-onset Alzheimer's disease. In 1992, Dr Goate moved to Washington University as an Associate Professor in Genetics and Psychiatry. Dr Goate and colleagues have since identified mutations in four other genes, including two that cause Alzheimer's disease and two that cause the related dementia frontotemporal dementia. In addition to her work on dementia, Dr Goate's laboratory also studies the genetics of alcohol and nicotine dependence. Dr Goate has received numerous awards including the Potamkin Award from the American Academy of Neurology, the Zenith Award from the Alzheimer's Association, the Senior Investigator Award from the Metropolitan Life Foundation, the St Louis Academy of Science Innovation Award and the Carl and Gerty Cori Faculty Achievement Award at Washington University. Dr Goate has been a member of many scientific Review Boards and currently serves on the Editorial Boards of several journals.
                    • Peter L Nagy, MD, PhD
                      Director of Next-Gen Sequencing Laboratory Laboratory of Personalized Genomic Medicine, Associate Professor, Columbia University
                      Biography
                        Peter L. Nagy is a biochemist and a physician, board certified in anatomic and molecular genetic pathology. <br /> <br />Dr. Nagy's research focuses on the role of transcriptional processing in the pathogenesis of neurodegenerative disorders. He developed S. pombe and M. musculus models for Ataxia-Oculomotor-Apraxia type 2 (AOA2) caused by mutations in the human ortholog of the yeast RNA helicase Sen1, Senataxin (SETX). Using these models they are working to define the pathomechanism of SETX mediated neurodegenerative disorders. They are also investigating the pathogenesis of ALS caused by C9orf72 expansions and search for novel ALS causing or modifying genetic variants.&nbsp; In Dr. Nagy's research, he combines the tools of classical biochemistry and genetics with genomics, most importantly next-gen sequencing for mutation discovery, transcriptome analysis and the identification of novel protein RNA interactions. <br /> <br />His clinical interest is the development and use of genome-scale sequencing assays in the clinical diagnosis of constitutional disorders and cancer such as : <br />&nbsp;&nbsp;&nbsp; * Mitochondrial Genome Sequencing Test <br />&nbsp;&nbsp;&nbsp; * Columbia Combined Genetic Panel (1300 genes most commonly associated with genetic disorders) <br />&nbsp;&nbsp;&nbsp; * Whole Exome Sequencing Tests for Constitutional Disorders and Cancer. <br /> <br />
                      • Katerina Venderova, PhD
                        Assistant Professor Department of Physiology and Pharmacology, University of the Pacific, Thomas J Long School of Pharmacy and Health Sciences
                        Biography
                          Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western Research Institute (2 years), and subsequently at University of Ottawa in Canada (5 years), where she studied genetics of Parkinson's disease, mechanisms of neuronal death and cell signaling in the basal ganglia. Dr. Venderova joined Pacific in 2011. <br />
                        • Margaret Sutherland, PhD
                          Program Director in the Neurodegeneration Cluster, NIH/NINDS
                          Biography
                            Dr. Margaret Sutherland joined the NINDS in 2007 and serves as a Program Director in the Neurodegeneration Cluster at NINDS. She currently oversees research grant portfolios and programs in: i) Huntington's Disease; ii) Frontotemporal Dementia and iii) basic and clinical studies supporting the genetics, protein flux, mitochondrial dynamics, synuclein biology and stem cell based-research associated with Parkinson's Disease. Dr. Sutherland manages the CINAPS contract which is designed to support pre-clinical validation of therapeutic targets for Parkinson's Disease. She also oversees consortia focused on the development and utilization of induced pluripotent stem cell resources for advancement of basic and translational research in neurodegenerative diseases. Dr. Sutherland received her undergraduate degree in Microbiology and Immunology from the University of Western Ontario and her Ph.D. in Molecular Neuroscience from the Laboratory of Molecular Biology (LMB), Cambridge UK. She completed her postdoctoral training with Dr. Jeffrey Noebels, in the Department of Neurology, at the Baylor College of Medicine where she developed transgenic mouse models of absence seizures (overexpression of voltage-gated K+ channels) and enhanced astroglial glutamate transport. Prior to joining the NINDS, Dr. Sutherland was a faculty member in the Center for Neuroscience Research at the Children's National Medical Center (CNMC), where she directed NIH-funded research programs on excitotoxicity mechanisms in neurodegeneration and epilepsy and served as director of the CNMC Transgenic Core facility.
                          • Stephen Scott, PhD
                            Professor Department of Biomedical and Molecular Sciences, Queens University School of Medicine
                            Biography
                              Dr. Stephen Scott is a professor in the Department of Biomedical and Molecular Sciences at Queen's University. He is also a member of the Centre for Neuroscience Studies and the CIHR Group in Sensory-Motor Systems. He graduated from the University of Waterloo in Systems Designs Engineering for his undergraduate degree and a M.A.Sc. with Dr. D.A. Winter. He then did a Ph.D. with Dr. Gerry Loeb at Queens University in the Department of Physiology. After that he went to the Universit de Montral for his postdoctoral training in the Department of Physiology with Dr. John Kalaska from 1993 to 1995. His first faculty position was as a chercheur adjoint in the Department of Physiology at Universit de Montral in 1995. He moved his lab to Queen's University in 1997.
                            • Orly Lazarov, PhD
                              Associate Professor of Anatomy and Cell Biology, University of Illinois College of Medicine
                              Biography
                                r. Lazarov started her scientific career as a graduate student at the Weizmann Institute of Science in Israel. There, she joined the research group of Professor Michal Schwartz, where she studied the cross talk between the immune system and the central nervous system in relation to nerve trauma. She was granted The Feinberg Graduate School Fellowship of Distinction for Outstanding Achievement in Studies and Research and the Feinberg Graduate School Award for Distinguished Ph.D. Students. After graduation she joined the research group of Professor Sangram S. Sisodia at the University of Chicago. Dr. Lazarov studied and characterized multiple aspects of Alzheimer's disease neuropathology. Her pioneering studies showed that in addition to genetics, environmental factors play a major role in the formation of Alzheimer's disease. Dr. Lazarov joined the Department of Anatomy and Cell Biology at the University of Illinois at Chicago in 2005, where she established a research group that studies neurogenesis and plasticity in aging and in Alzheimer's disease.
                              • Lana Morrow, PhD
                                Founder and CEO, Think Interfaces, Inc.
                                Biography
                                  Dr. Morrow earned a doctorate degree in cognitive neuroscience from La Sapienza University in Rome, Italy, and went on to train at Mount Sinai Hospital in New York City at the invitation of professor Melvin Yahr. While working at the neurology department of Mount Sinai, she conducted studies using EEG-based brain mapping techniques with Parkinsons patients. Afterwards she received further education and training in Clinical Neuropsychology under Dr. Yaakov Stern at Columbia Presbyterian Hospital in New York City. As a Clinical Neuropsychologist, she has over 20 years experience assessing and treating adults and children with various learning and neurological issues, specializing in the treatment of learning disabilities, attention deficit disorder and the differential diagnosis of complex brain disorders. As a neuroscientist, she used visual evoked potentials and other neuroimaging modalities to study brain functioning, completing successful research collaborations with major universities in Europe and the United States. Most recently, Dr. Morrow developed a dry electrode wireless EEG headset and brain-computer interface that incorporates advancements from different branches of science and technology. Dr. Morrows vision is to help improve the quality of life for children and adults using simple, non-invasive systems. One of her companies, THINK Interfaces, Inc., was created to provide patients with non-invasive, non-pharmacological methods for the diagnosis and remediation of patients with ADD/ADHD, Parkinsons Disease, Alzheimers Disease, and age-related cognitive capacity, memory and focus deficits. Her system is currently in clinical trials on children with ADD/ADHD. Dr. Morrow collaborates with top scientists and engineers from leading universities around the world with the aim of conducting multidisciplinary clinical research and the development of hardware and software products for the purpose of delivering tangible benefits to millions around the globe.
                                • Evan W. Snyder, M.D., Ph.D., F.A.A.P
                                  Director Stem Cell Research Center &amp; Core Facility, Professor, Sanford-Burnham Medical Research Inst, Faculty Physician, Department of Pediatrics, University of California, San Diego
                                  Biography
                                    Evan Y. Snyder earned his M.D. and Ph.D. (in neuroscience) from the University of Pennsylvania in 1980 as a member of NIH's Medical Scientist Training Program (MSTP). He had also studied psychology and linguistics at the University of Oxford. After moving to Boston in 1980, he completed residencies in pediatrics and neurology as well as a clinical fellowship in Neonatal-Perinatal Medicine at Children's Hospital-Boston, Harvard Medical School. He also served as Chief Resident in Medicine (1984-85) and Chief Resident in Neurology (1987) at Children's Hospital-Boston. In 1989, he became an attending physician in the Department of Pediatrics (Division of Newborn Medicine) and Department of Neurology at Children's Hospital-Boston, Harvard Medical School. From 1985-91, concurrent with his clinical activities, he conducted postdoctoral research as a fellow in the Department of Genetics, Harvard Medical School. In 1992, Dr. Snyder was appointed an instructor in neurology (neonatology) at Harvard Medical School and was promoted to assistant professor in 1996. He maintained lab spaces in both Children's Hospital-Boston and at Harvard Institutes of Medicine/Beth-Israel Deaconess Medical Center. In 2003, Dr. Snyder was recruited to Sanford-Burnham Medical Research Institute as Professor and Director of the Program in Stem Cell and Regenerative Biology. He then inaugurated the Stem Cell Research Center (serving as its founding director) and initiated the Southern California Stem Cell Consortium. Dr. Snyder is a Fellow of the American Academy of Pediatrics (FAAP). He also received training in Philosophy and Linguistics at Oxford University.
                                  • Prashanthi Vemuri, PhD
                                    Assistant Professor at the Aging and Dementia Imaging Laboratory, Department of Radiology, Mayo Clinic
                                    Biography
                                      Dr. Vemuri is an Assistant Professor at the Aging and Dementia Imaging Laboratory, Department of Radiology, Mayo Clinic Rochester. She has a Masters and Doctorate from the Department of Electrical Engineering at University of Utah, Salt Lake City with a major in Medical Imaging. She completed a fellowship with Dr. Clifford Jack at the Mayo Clinic in imaging of neurodegenerative diseases. She is a recipient of the NIH K99/R00 Pathway to Independence grant from the NIA, Alzheimers Association New Investigator grant award and was recently awarded the AFAR-GE healthcare junior investigator award for excellence in aging and imaging research. Dr. Vemuris areas of research are developing and validating biomarkers to improve the understanding and management of Alzheimers disease and related disorders and utilize biomarkers to improve our understanding of cognitive reserve i.e. the disconnect between pathology and cognitive performance in individuals.
                                    • David Van Essen, PhD
                                      Professor of Anatomy and Neurobiology, Washington University School of Medicine
                                      Biography
                                        Dr. Van Essen is currently Edison Professor and Head of the Anatomy & Neurobiology Department at Washington University in St. Louis. He has served as Editor-in-Chief of the Journal of Neuroscience, founding chair of the Organization for Human Brain Mapping, and President of the Society for Neuroscience. He is a fellow of the AAAS and has received the Peter Raven Lifetime Achievement Award from the St. Louis Academy of Science and the Krieg Cortical Discoverer Award from the Cajal Club. Dr. Van Essen received his undergraduate degree in Chemistry in 1967 from Caltech and his graduate degree in neurobiology in 1971 from Harvard. He was a postdoctoral fellow at Harvard under Drs. David Hubel and Torsten Wiesel and did additional postdoctoral work in Norway and England before returning to Caltech in 1976. He was a faculty member in the Division of Biology at Caltech until 1992, during which time he served as Executive Officer for Neurobiology (1982-1989) and Option Representative for the Computation and Neural Systems program (1986-1991). In 1992 he became Edison Professor of Neurobiology and Head of the Department of Anatomy and Neurobiology at Washington University School of Medicine. Dr. Van Essen is internationally known for his research on how the brain organizes and processes visual information. He has made extensive contributions to the understanding of how the brain perceives shape, motion and color and how attention affects neural activity. His work has helped to demonstrate that the brain contains dozens of different areas involved in vision and that these areas are interconnected by hundreds of distinct neural pathways. He and his colleagues have developed powerful new techniques in computerized brain mapping to analyze these visual areas in humans as well as nonhuman primates. This work includes the continued development of an integrated suite of software tools for surface-based analyses of cerebral cortex. These methods are applied to the analysis of cortical structure and function in humans, monkeys and rodents. A broad objective is to develop probabilistic surface-based atlases that accurately convey commonalities as well as differences between individuals.
                                      • Edward S. Boyden, PhD
                                        Joint Professor at MIT, Synthetic Neurobiology Research Group, AT&amp;T Career Development Associate Professor, MIT
                                        Biography
                                          Professor Boyden leads the MIT Synthetic Neurobiology research group, which develops tools for mapping, controlling, observing, and building Brain Circuits. His research group has invented a suite of "optogenetic" tools that are now in use by thousands of research groups around the world for activating and silencing neurons with light. Boyden was named to the "Top 35 Innovators Under the Age of 35" by Technology Review in 2006, and to the "Top 20 Brains Under Age 40" by Discover magazine in 2008. He has received the Gabbay Award, National Institutes of Health (NIH) Director's Pioneer Award and Transformative Research Award, the Society for Neuroscience Research Award for Innovation in Neuroscience, the NSF Career Award, the Paul Allen Distinguished Investigator Award, and the New York Stem Cell Robertson Investigator Award. In 2010, his work was recognized as the "Method of the Year" by the journal Nature Methods. Most recently he shared the 2013 Grete Lundbeck European Brain Research Prize for outstanding contributions to European neuroscience-the largest neuroscience prize in the world
                                        • Scott W. Emmons, PhD
                                          Siegfried Ullmann Professor of Genetics, Professor of Neuroscience, Albert Einstein College of Medicine
                                          Biography
                                            Dr. Emmons is the Siegfried Ullmann Professor of Genetics and Professor of Neuroscience at the Albert Einstein College of Medicine. Dr. Emmons received his PhD from Stanford University. He carried out postdoctoral work at the Carnegie Institution of Washington, Department of Embryology, Baltimore, and at the University of Colorado, Boulder. Dr. Emmons has been studying the nematode worm Caenorhabditis elegans for over 30 years. Initially he analyzed genome structure. Later he turned his attention to developmental studies, focusing on development of the C. elegans male as a model for understanding the genetic specification and evolution of morphology. This work led to the identification of a number of regulatory genes and contributed to the understanding of genetic specification of cell fate, including patterning of neurotransmitters in the nervous system. Current focus is on male behavior and the structure, development, and genetic specification of the nervous system. The laboratory has recently determined the wiring diagram of the nervous system of the adult male. This is one of the first results in the new field of connectomics. A connectome is a complete map of a nervous system, including all the synaptic connections. Currently the laboratory is interested in studying the development of connectivity during growth and in identifying the genes that specify individual connections.
                                          • Emery N. Brown, MD, PhD, William Newsome, PhD, Justin Sanchez, PhD, Terrence J Sejnowski, PhD
                                            Emery N. Brown, MD, PhD Warren M. Zapol Prof. of Anaesthesia Harvard Medical School, Prof. of Computational Neuroscience MIT, Director, Neuroscience Statistics Research Laboratory, Anestheti
                                            Biography
                                              Emery N. Brown, M.D., Ph.D. is the Warren M. Zapol Professor of Anaesthesia at Harvard Medical School, a Professor of Computational Neuroscience at the Massachusetts Institute of Technology and a Professor of Health Sciences and Technology at the Harvard-MIT Division of Health Sciences and Technology. Brown is the Director of the Neuroscience Statistics Research Laboratory at the Massachusetts Institute of Technology, the co-director of the Harvard-MIT Division of Health Sciences and Technology and an associate director of M.I.T.'s Institute for Medical Engineering & Science.[1] Brown also works as a doctor in the department of anesthesiology, critical care and pain medicine at Massachusetts General Hospital.[2] In 2007, Brown was one of the recipients of the National Institutes of Health Director's Pioneer Award.[3] Brown is a fellow of the American Academy of Arts and Sciences, the Institute of Electrical and Electronics Engineers and the American Association for the Advancement of Science. Bill Newsome is an Investigator of the Howard Hughes Medical Institute and Professor of Neurobiology at the Stanford University School of Medicine. He received a B.S. degree in physics from Stetson University and a Ph.D. in biology from the California Institute of Technology. Dr. Newsome is a leading investigator in systems and cognitive neuroscience. He has made fundamental contributions to our understanding of the neural mechanisms underlying visual perception and simple forms of decision making. Among his honors are the Rank Prize in Optoelectronics, the Spencer Award, the Distinguished Scientific Contribution Award of the American Psychological Association, the Dan David Prize of Tel Aviv University, the Karl Spencer Lashley Award of the American Philosophical Society, and the Champalimaud Vision Award. His distinguished lectureships include the 13th Annual Marr Lecture at the University of Cambridge the 9th Annual Brenda Milner Lecture at McGill University, and most recently, the Distinguished Visiting Scholar lectures at the Kavli Institute of Brain and Mind, UCSD. He was elected to membership in the National Academy of Sciences in 2000, and to the American Philosophical Society in 2011. Dr. Justin Sanchez joined DSO as a program manager in 2013. At DARPA, Dr. Sanchez will explore neurotechnology, brain science and systems neurobiology. Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourettes syndrome and Obsessive-Compulsive Disorder. Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system. He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoDs Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology. Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida. Terrence Sejnowski is a pioneer in computational neuroscience and his goal is to understand the principles that link brain to behavior. His laboratory uses both experimental and modeling techniques to study the biophysical properties of synapses and neurons and the population dynamics of large networks of neurons. New computational models and new analytical tools have been developed to understand how the brain represents the world and how new representations are formed through learning algorithms for changing the synaptic strengths of connections between neurons. He has published over 300 scientific papers and 12 books, including The Computational Brain, with Patricia Churchland. He received his PhD in physics from Princeton University and was a postdoctoral fellow at Harvard Medical School. He was on the faculty at the Johns Hopkins University and he now holds the Francis Crick Chair at The Salk Institute for Biological Studies and is also a Professor of Biology at the University of California, San Diego, where he is co-director of the Institute for Neural Computation and co-director of the NSF Temporal Dynamics of Learning Center. He is the President of the Neural Information Processing Systems (NIPS) Foundation, which organizes an annual conference attended by over 1000 researchers in machine learning and neural computation and is the founding editor-in-chief of Neural Computation published by the MIT Press. An investigator with the Howard Hughes Medical Institute, he is also a Fellow of the American Association for the Advancement of Science and a Fellow of the Institute of Electrical and Electronics Engineers. He has received many honors, including the NSF Young Investigators Award, the Wright Prize for interdisciplinary research from the Harvey Mudd College, the Neural Network Pioneer Award from the Institute of Electrical and Electronics Engineers and the Hebb Prize from the International Neural Network Society. He was elected to the Institute of Medicine in 2008, to the National Academy of Sciences in 2010, and to the National Academy of Engineering in 2011. He is one of only 10 living persons to be a member of all 3 national academies.
                                            • Emery N. Brown, MD, PhD, William Newsome, PhD, Justin Sanchez, PhD, Terrence J Sejnowski, PhD
                                              Emery N. Brown, MD, PhD Warren M. Zapol Prof. of Anaesthesia Harvard Medical School, Prof. of Computational Neuroscience MIT, Director, Neuroscience Statistics Research Laboratory, Anestheti
                                              Biography
                                                Emery N. Brown, M.D., Ph.D. is the Warren M. Zapol Professor of Anaesthesia at Harvard Medical School, a Professor of Computational Neuroscience at the Massachusetts Institute of Technology and a Professor of Health Sciences and Technology at the Harvard-MIT Division of Health Sciences and Technology. Brown is the Director of the Neuroscience Statistics Research Laboratory at the Massachusetts Institute of Technology, the co-director of the Harvard-MIT Division of Health Sciences and Technology and an associate director of M.I.T.'s Institute for Medical Engineering & Science.[1] Brown also works as a doctor in the department of anesthesiology, critical care and pain medicine at Massachusetts General Hospital.[2] In 2007, Brown was one of the recipients of the National Institutes of Health Director's Pioneer Award.[3] Brown is a fellow of the American Academy of Arts and Sciences, the Institute of Electrical and Electronics Engineers and the American Association for the Advancement of Science. Bill Newsome is an Investigator of the Howard Hughes Medical Institute and Professor of Neurobiology at the Stanford University School of Medicine. He received a B.S. degree in physics from Stetson University and a Ph.D. in biology from the California Institute of Technology. Dr. Newsome is a leading investigator in systems and cognitive neuroscience. He has made fundamental contributions to our understanding of the neural mechanisms underlying visual perception and simple forms of decision making. Among his honors are the Rank Prize in Optoelectronics, the Spencer Award, the Distinguished Scientific Contribution Award of the American Psychological Association, the Dan David Prize of Tel Aviv University, the Karl Spencer Lashley Award of the American Philosophical Society, and the Champalimaud Vision Award. His distinguished lectureships include the 13th Annual Marr Lecture at the University of Cambridge the 9th Annual Brenda Milner Lecture at McGill University, and most recently, the Distinguished Visiting Scholar lectures at the Kavli Institute of Brain and Mind, UCSD. He was elected to membership in the National Academy of Sciences in 2000, and to the American Philosophical Society in 2011. Dr. Justin Sanchez joined DSO as a program manager in 2013. At DARPA, Dr. Sanchez will explore neurotechnology, brain science and systems neurobiology. Before coming to DARPA, Dr. Sanchez was an Associate Professor of Biomedical Engineering and Neuroscience at the University of Miami, and a faculty member of the Miami Project to Cure Paralysis. He directed the Neuroprosthetics Research Group, where he oversaw development of neural-interface medical treatments and neurotechnology for treating paralysis and stroke, and for deep brain stimulation for movement disorders, Tourettes syndrome and Obsessive-Compulsive Disorder. Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans where he studied the activity of single neurons, local field potentials and electrocorticogram in the cerebral cortex and from deep brain structures of the motor and limbic system. He has published more than 75 peer-reviewed papers, holds seven patents in neuroprosthetic design and authored a book on the design of brain-machine interfaces. He has served as a reviewer for the NIH Neurotechnology Study Section, DoDs Spinal Cord Injury Research Program and the Wellcome Trust, and as an associate editor of multiple journals of biomedical engineering and neurophysiology. Dr. Sanchez holds Doctor of Philosophy and Master of Engineering degrees in Biomedical Engineering, and a Bachelor of Science degree in Engineering Science, all from the University of Florida. Terrence Sejnowski is a pioneer in computational neuroscience and his goal is to understand the principles that link brain to behavior. His laboratory uses both experimental and modeling techniques to study the biophysical properties of synapses and neurons and the population dynamics of large networks of neurons. New computational models and new analytical tools have been developed to understand how the brain represents the world and how new representations are formed through learning algorithms for changing the synaptic strengths of connections between neurons. He has published over 300 scientific papers and 12 books, including The Computational Brain, with Patricia Churchland. He received his PhD in physics from Princeton University and was a postdoctoral fellow at Harvard Medical School. He was on the faculty at the Johns Hopkins University and he now holds the Francis Crick Chair at The Salk Institute for Biological Studies and is also a Professor of Biology at the University of California, San Diego, where he is co-director of the Institute for Neural Computation and co-director of the NSF Temporal Dynamics of Learning Center. He is the President of the Neural Information Processing Systems (NIPS) Foundation, which organizes an annual conference attended by over 1000 researchers in machine learning and neural computation and is the founding editor-in-chief of Neural Computation published by the MIT Press. An investigator with the Howard Hughes Medical Institute, he is also a Fellow of the American Association for the Advancement of Science and a Fellow of the Institute of Electrical and Electronics Engineers. He has received many honors, including the NSF Young Investigators Award, the Wright Prize for interdisciplinary research from the Harvey Mudd College, the Neural Network Pioneer Award from the Institute of Electrical and Electronics Engineers and the Hebb Prize from the International Neural Network Society. He was elected to the Institute of Medicine in 2008, to the National Academy of Sciences in 2010, and to the National Academy of Engineering in 2011. He is one of only 10 living persons to be a member of all 3 national academies.
                                              • Lana Morrow, PhD
                                                Founder and CEO, Think Interfaces, Inc.
                                                Biography
                                                  Dr. Morrow earned a doctorate degree in cognitive neuroscience from La Sapienza University in Rome, Italy, and went on to train at Mount Sinai Hospital in New York City at the invitation of professor Melvin Yahr. While working at the neurology department of Mount Sinai, she conducted studies using EEG-based brain mapping techniques with Parkinsons patients. Afterwards she received further education and training in Clinical Neuropsychology under Dr. Yaakov Stern at Columbia Presbyterian Hospital in New York City. As a Clinical Neuropsychologist, she has over 20 years experience assessing and treating adults and children with various learning and neurological issues, specializing in the treatment of learning disabilities, attention deficit disorder and the differential diagnosis of complex brain disorders. As a neuroscientist, she used visual evoked potentials and other neuroimaging modalities to study brain functioning, completing successful research collaborations with major universities in Europe and the United States. Most recently, Dr. Morrow developed a dry electrode wireless EEG headset and brain-computer interface that incorporates advancements from different branches of science and technology. Dr. Morrows vision is to help improve the quality of life for children and adults using simple, non-invasive systems. One of her companies, THINK Interfaces, Inc., was created to provide patients with non-invasive, non-pharmacological methods for the diagnosis and remediation of patients with ADD/ADHD, Parkinsons Disease, Alzheimers Disease, and age-related cognitive capacity, memory and focus deficits. Her system is currently in clinical trials on children with ADD/ADHD. Dr. Morrow collaborates with top scientists and engineers from leading universities around the world with the aim of conducting multidisciplinary clinical research and the development of hardware and software products for the purpose of delivering tangible benefits to millions around the globe.
                                                • Anthony Grace, PhD
                                                  Distinguished Professor of Neuroscience, Professor of Psychiatry and Psychology Department of Neuroscience, University of Pittsburgh
                                                  Biography
                                                    Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA.&nbsp; He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral training with Dr. Rodolfo Llinas in the Department of Physiology and Biophysics at New York University School of Medicine.&nbsp; Dr. Grace has been involved in translational research related to the dopamine system for over 30 years.&nbsp;&nbsp; His early work pioneered the mode of action of antipsychotic drugs, and the identification and characterization of dopamine-containing neurons, and was the first to provide a means to quantify their activity state and pattern in a way that is the standard in the literature.&nbsp; His current work involves novel treatments for schizophrenia and its prevention, the role of dopamine in anhedonia and affective disorders, and the mode of action of ketamine and novel antidepressant drugs.&nbsp; Dr. Grace has received several awards for his research, including the Paul Janssen Schizophrenia Research Award and the Lilly Basic Scientist Award from the International College of Neuropsychopharmacology, the Efron Award from the American College of Neuropsychopharmacology, as well as a NIMH MERIT award, a Distinguished Investigator award from the National Alliance for Research in Schizophrenia and Depression, the Judith Silver Memorial Investigator Award from the National Alliance for the Mentally Ill, a Fellow of the American Association for the Advancement of Science, and appointment as a Distinguished Professor of Neuroscience at the University of Pittsburgh.&nbsp; He is also a past member of the governing council of the American College of Neuropsychopharmacology and is on the editorial board fornumerous leading journals in the field. <br />
                                                  • Kristen Harris, PhD
                                                    Associate Chair, Department of Neuroscience, Professor of Neuroscience , Fellow Center for Learning and Memory, University of Texas at Austin
                                                    Biography
                                                      Dr. Harris's goal is to elucidate the structural components involved in the cell biology of learning and memory. She has quantified the basic ultrastructure of synapses in several brain regions using reconstruction from serial section transmission electron microscopy (ssTEM). Her focus has been on dendritic spines because they are the major postsynaptic targets of excitatory axons throughout the brain and because their structure and composition serve both synaptic plasticity and stabilizing homeostatic mechanisms. She has developed and maintains an NIH-supported educational website on the ultrastructure of synapses. Dr. Kristen Harris received her PhD in Neuroscience in 1982 from the Northeastern Ohio Universities College of Medicine in Rootstown Ohio with Dr. Timothy Teyler, when she established postnatal day 15 as the earliest age to express enduring long-term potentiation. In 1984 she completed postdoctoral research in serial section transmission electron microscopy with Dr. Dennis Landis at Harvard Medical School and Dr. John Stevens at the University of Toronto. She then became a member of the faculty in Neurology at the Harvard Medical School and Children's Hospital, Boston where she remained until 1999. In 1999 she moved as tenured full professor to Boston University where she helped to establish an inter-departmental Program in Neuroscience. In 2002 she became a Georgia Research Alliance Eminent Scholar at the Medical College of Georgia where she established the Synapses and Cognitive Neuroscience Center and initiated the Human Brain Laboratory and recruited Dr. Sergei Kirov as its director. In 2006, she was recruited to the new Center for Learning and Memory at the University of Austin at Texas where she is currently Professor in Neurobiology.
                                                    • Daniel Suter, PhD
                                                      Associate Professor, Department of Biological Sciences, Purdue University
                                                      Biography
                                                        Dr. Daniel Suter studied Biology at the ETH Zurich in Switzerland, receiving an MS degree in Biological Sciences in 1988. After pursuing additional training in Biology and Chemistry Education at the ETH Zurich, he conducted graduate research on neuronal cell adhesion molecules with Prof. Peter Sonderegger in the Department of Biochemistry at the University of Zurich.&nbsp; After receiving a PhD in Biochemistry in 1995, he joined the laboratory of Prof. Paul Forscher at Yale University as a Postdoctoral fellow with support from the Swiss National Science Foundation and the Roche Research Foundation. During his time at Yale University, Dr. Suter made significant contributions to the understanding of the underlying mechanisms of neuronal growth cone motility and guidance, using quantitative high-resolution live cell imaging techniques. For example, he provided the first direct experimental evidence that support the model of substrate-cytoskeletal coupling during growth cone migration. <br /> <br />In 2003, he started his own lab at Purdue University as an Assistant Professor of Biological Sciences, continuing to unravel the basic mechanisms that control the directional movements of neuronal growth cones. His independent research program has focused on (1) the role of microtubules in growth cone guidance, (2) the dynamics and function of Src tyrosine kinase in growth cones, (3) the role of reactive oxygen species in controlling the neuronal cytoskeleton, and (4) the biomechanics of growth cones. Since 2009, Dr. Suter is an Associate Professor of Biological Sciences in the Department of Biological Sciences at Purdue University. <br />
                                                      • Michael Salter, MD, PhD, FRSC
                                                        Head and Senior Scientist of Neurosciences &amp; Mental Health, Associate Chief of Science Strategy Research, Sick Kids Research Institute
                                                        Biography
                                                          Dr. Michael Salter is Senior Scientist in the Neurosciences & Mental Health Program at The Hospital for Sick Children (SickKids) Research Institute, and a professor at the University of Toronto. He holds the Canada Research Chair in Neuroplasticity and Pain, and is the Anne and Max Tanenbaum Chair in Molecular Medicines. He has authored more than 120 scientific papers, reviews and book chapters. Dr. Salter is best known for his work on synaptic physiology and he has done groundbreaking work that has led to new paradigms about neuroplasticity and about how synaptic transmission in the central nervous system is regulated by biochemical processes within neurons and by glial-neuronal interactions. His discoveries have broad implications for the control of cell-cell communication throughout the nervous system and his work has regularly appeared in elite journals including Nature, Science, Cell, Nature Medicine and Neuron. Notwithstanding his present focus on molecular/cellular aspects of pain he has published work on many aspects of the pain experience including clinical studies on bio-behavioural aspects of chronic pain in patients. Dr. Salter received an MD degree from the University of Western Ontario in 1982 and went on to obtain a PhD in Physiology from McGill in 1987. After post-doctoral training at Toronto Western and Mt. Sinai hospitals he joined the Research Institute at SickKids in 1990, with an academic appointment in the Department of Physiology at the University of Toronto. He moved rapidly through the ranks and is currently Head of the Neurosciences & Mental Health Program and Associate Chief, Science Strategy at SickKids, and a Professor of Physiology, IMS and Dentistry at UofT. Dr. Salter was the founding Director of the University of Toronto Centre for the Study of Pain an initiative which spans the Faculties of Medicine, Nursing, Dentistry and Pharmacy. In the Centre, he brought together a diverse group of more than 60 pain researchers and academics in the University of Toronto community. Dr. Salter is also a founder and Vice-President of NoNO Inc. a biotechnology company based in Toronto that is developing novel therapeutic agents for the treatment of stroke, neurodegeneration, neurotrauma and pain by targeting protein-protein interactions within neurons in the brain and spinal cord.
                                                        • Benjamin Greenberg, MD
                                                          Associate Professor Cain Denius Scholar in Mobility Disorders, Department of Neurology &amp; Neurotherapeutics, Pediatrics, UT Southwestern Medical Center
                                                          Biography
                                                            Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He attended medical school at Baylor College of Medicine in Houston, Texas. Then, he completed an internship in medicine at Rush Presbyterian-St. Luke?s Medical Center in Chicago, Illinois before going on to his residency in neurology at The Johns Hopkins Hospital in Baltimore, MD. He then joined the faculty within the division of neuroimmunology at Hopkins and became the co-director of the Transverse Myelitis Center and director of the Encephalitis Center. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. His research interests are in both the diagnosis and treatment of multiple sclerosis, transverse myelitis, neuromyelitis optica and infections of the nervous system. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected.
                                                          • Ari Green, MD
                                                            Director of UCSF Neurodiagnostics Center, Director of UCSF Multiple Sclerosis Center, Rachleff Endowed Professor, Associate Professor of Neurology and Opthalmology, UCSF School of Medicine
                                                            Biography
                                                              Dr. Ari J. Green is Clinical Director of the UCSF Multiple Sclerosis (MS) Center and director of the UCSF Neurodiagnostics Center. He treats adults and children with MS and other inflammatory diseases of the central nervous system and has expertise in treating visual problems resulting from these conditions. In his research, he addresses how MS affects the visual system and methods to track and predict the course of the disease. He also uses advanced retinal imaging and electrophysiology to investigate the retina and optic nerve and the relationships between inflammation, demyelination and neurodegeneration in the disease and to better understand injury to nerve fibers of the brain in MS. <br /> <br />Green earned a medical degree at Duke University School of Medicine in Durham, N.C., and completed an internal medicine internship in 2002 and neurology residency in 2005, both at UCSF. In 2005, he was chief resident at UCSF. He completed neuro-immunology and neuro-ophthalmology fellowships at UCSF and has won several awards including a Howard Hughes Medical Institute Early Career Scientist Award and a clinician-scientist award from the National Multiple Sclerosis Society and American Academy of Neurology Foundation. Green is an associate professor of Neurology and Opthalmology at UCSF. <br />
                                                            • Pierre-Antoine Gourraud, PhD, MPH
                                                              Assistant Adjunct Professor of Neurology, University of California, San Francisco
                                                              Biography
                                                                Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the United States to do his postdoctoral research in Neuroimmunogenetics of multiple sclerosis at UCSF in 2009 and joined the UCSF faculty in 2011. Dr Gourraud has established numerous research collaborations with investigators from all over the world: He develops bioinformatics resources at the National Center for Biotechnology Information (Immunogenetics markers: HLA, KIR, Microsatellites). At UCSF, he performs new generation of MS genetic association studies using massive sequencing technologies in various genetic ancestry backgrounds and continues developing software dedicated to translational digital medicine. His recent efforts have focused on the MS Bioscreen, a tablet-based navigation-system that integrates multiple dimensions of patient information including clinical evolution, therapeutic treatments, brain imaging, genomics and biomarker data.
                                                              • Susan Catalano, PhD
                                                                Founder and Chief Science Officer, Cognition Therapeutics, Inc.
                                                                Biography
                                                                  Dr. Susan Catalano received her B.A. from Barnard College and Ph.D. from U.C. Irvine. She completed her postdoctoral training at U.C. Berkeley and Caltech in the field of neurobiology. While a scientist at Roche Palo Alto, she led the Neurophysiology and Neuroimaging groups along with anexploratory program in psychiatric disorders. After Roche, Dr. Catalano joined Rigel Pharmaceuticals, Inc. and led the team that discovered the Aurora kinase inhibitor R763, (licensed to Serono for $135M in 2005.) Dr. Catalano founded a successful consulting practice, Drug Discovery Imaging, and then served as Director of Discovery Biology for Acumen Pharmaceuticals, Inc. Dr. Catalano founded Cognition Therapeutics Inc (www.cogrx.com) in 2007 to discover and develop drugs to treat and prevent Alzheimers disease and currently serves as its Chief Science Officer. The company is currently advancing its candidate drugs towards the clinic. She also volunteers as the Executive Scientific Director of Pittsburgh-based nonprofit the Clear Thoughts Foundation and holds an adjunct appointment at the University of Pittsburgh School of Medicine.
                                                                • Radosveta Koldamova, MD, PhD
                                                                  Associate Professor at the Department of Environmental &amp; Occupational Health, University of Pittsburgh
                                                                  Biography
                                                                    Radosveta (Rada) Koldamova, MD, PhD is Associate Professor at the Department of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA. Dr. Koldamova research has been distinguished by groundbreaking findings in the area of Nuclear Receptor biology in brain and their targets, relevant to AD pathogenesis and therapy. Prior to her appointment at Pitt in 1995, Dr. Koldamova served as a General Practitioner and an Instructor and Lecturer in Biochemistry at the School of Medicine, Stara Zagora, Bulgaria. She defended her PhD thesis in Biochemistry and Molecular Biology at the Bulgarian Academy of Sciences. From 1995 to 2005, she was a postdoctoral fellow and then Assistant Professor at the Department of Pharmacology, School of Medicine University of Pittsburgh. While at Pharmacology, Dr. Koldamova discovered the role of cholesterol transporter ABCA1 and its transcriptional regulators LXR/RXR in AD using in vitro and in vivo model systems. The original reports published by Dr. Koldamova on biology of brain LXR, ABCA1 and therapeutic approaches for AD based on ligand activated NR established a new and fruitful area of AD research. Dr. Koldamova has served on numerous academic, scientific, and professional committees. She is a member of the Society for Neuroscience, International Society to Advance Alzheimer Research and Treatment, and American Society for Biochemistry and Molecular Biology, and is a Principal Investigator on Federal Agencies and Private foundations funded grant awards.
                                                                  • Ahmad Salehi, MD, PhD
                                                                    Clinical Associate Professor Department of Psychiatry &amp; Behavioral Sciences, Stanford Medical School
                                                                    Biography
                                                                      Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran and then moved to the Netherlands Institute for Brain Research, in Amsterdam to get his PhD. While he was there, he was selected as the best junior scientist in the field of Alzheimers disease in the Netherlands. After finishing his graduate studies and 3 years of postdoc in Amsterdam, he moved to Stanford Medical School. First as a postdoc, and then as a Senior Research Associate, he worked on mechanisms of failed axonal transport in mouse models of Down syndrome. For almost a decade, he was the Director of Stanford Brain Bank. Since 2009, Dr. Salehi has moved to the Department of Psychiatry and Behavioral Sciences at Stanford. In December 2010, he received the World Technology Award in the field of Biotechnology for his innovative work on the use of mouse models of Down syndrome. During his carrier, Ahmad has been involved in publication of a large number of papers from which several have appeared on the cover of Science, Cell: Stem Cell, Science Translational Medicine, Neuroscience and Bio-behavior Reviews, and Biological Psychiatry (twice).
                                                                    • Bryan L. Roth, MD, PhD
                                                                      Michael Hooker Distinguished Professor, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy
                                                                      Biography
                                                                        Bryan L. Roth MD, PhD is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Chapel Hill School of Medicine. Dr. Roth received his MD and PhD (Biochemistry) from St. Louis University in 1983 and subsequently training in pharmacology (NIH), molecular biology and psychiatry (Stanford) . Dr. Roth has published more than 400 papers in the general area of the molecular pharmacology of drug actions, including a large number of papers published in Science, Nature and Cell over the past decade. Dr. Roth has more than 40 patents and has founded 2 companies. Dr. Roth has been elected to the National Academy of Medicine of the National Academy of Sciences and has received many honors including the Goodman and Gilman Award for Receptor Pharmacology (ASPET; 2016), the PhRMA Foundation Excellence in Pharmacology Award, and a NARSAD Distinguished Investigator Award. Dr. Roth also given many endowed lectures including the Goodman, Koppyani, Strongwater, Niznik, Swammerdam, Lowenthal, S.G. Fergusson, Chauncy Leake and Philip S. Portoghese Lectures. Dr. Roth has also been named the 2018 IUHPAR Lecturer in Analytical Pharmacology (IUPHAR), the 2017 Martin S. Rodbell Lecturer and the inaugural 2017 Elliot Saul Vessell Visiting Professor. Dr. Roth has also been named a Thompson Reuters 'Highly Cited Scientist' in Pharmacology and in Biology and Biochemistry.
                                                                      • Stephanie Willerth, PhD
                                                                        Assistant Professor, University of Victoria Engineering, Canada
                                                                        Biography
                                                                          Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue by combining pluripotent stem cells, controlled drug delivery and biomaterial scaffolds . She has given invited talks at the Till and McCulloch Annual Meeting and at the 1st Annual British Columbia Stem Cell and Regeneration Medicine Initiative Meeting as well as presented at the 9th Annual World Biomaterials Congress in Chengdu, China. She belongs to both the Brain Research Centre (BRC) and the International Collaboration on Repair Discoveries (ICORD) - B.C. based organizations committed to treating brain diseases and disorders and finding long term treatments for the repair of spinal cord injuries respectively. Before accepting her faculty position, Dr. Willerth completed an NIH post doctoral fellowship at the University of California-Berkeley and graduate studies at Washington University.
                                                                        • Peter Glick, PhD
                                                                          Henry Merritt Wriston Professor of the Social Sciences, Professor of Psychology, Lawrence University
                                                                          Biography
                                                                            Peter Glick is a Professor of Psychology at Lawrence University in Appleton, Wisconsin. He received his A.B. in psychology from Oberlin College in 1979 and his Ph.D. in social psychology from the University of Minnesota in 1984. Glick and frequent collaborator Susan T. Fiske received the 1995 Gordon Allport Intergroup Relations Prize, honoring the "best paper or article of the year on intergroup relations" for "The Ambivalent Sexism Inventory: Differentiating Hostile and Benevolent Sexism." Research interests: how the structure of intergroup relations affects prejudice, stereotyping, and discrimination; and how subjectively positive stereotypes (e.g., women are warm and nurturing, Jews are clever) can nevertheless feed into discrimination (e.g., paternalistic prejudice toward women, envious prejudice toward Jews).
                                                                          • David N. Kennedy, PhD
                                                                            Professor, Univ of Massachusettes Medical School, Department of Psychiatry, Director of the Division of Neuroinformatics at the Child and Adolescent Neurodevelopment Initiative
                                                                            Biography
                                                                              Dr. Kennedy is a Professor of Psychiatry at the University of Massachusetts Medical School. He is Director of the Division of Neuroinformatics at the Child and Adolescent Neurodevelopment Initiative (CANDI). He has extensive expertise in the development of image analysis techniques and was a co-founder of the Center for Morphometric Analysis (CMA) at the Massachusetts General Hospital. His career has seen participation in the advent of such technologies as MRI-based morphometric analysis (1989), functional MRI (1991) and diffusion tensor pathway analysis (1998). He has long standing experience with development of neuroinformatics resources (Internet Brain Volumetric Database, Internet Brain Segmentation Repository, Internet Analysis Tools Registry), and participated as co-PI (PI: Bruce Rosen) of the morphometry Biomedical Informatics Research Network (mBIRN). Dr. Kennedy is the community liaison for the Neuroimaging Informatics Tools and Resources Clearinghouse (NITRC). In addition, he is a founding editor of the journal Neuroinformatics that debuted in 2003.
                                                                            Sponsored By

                                                                            For information on becoming a sponsor or exhibitor, please click here.


                                                                            Continuing Education (CME/CE/CEU) Credits

                                                                            The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                                                            Committee

                                                                            To download the Program Committee brochure here.


                                                                            • Bruce Hollis, PhD

                                                                              Bruce W. Hollis, Ph.D. received his B.Sc. and M.Sc. from the Ohio State University and subsequently his Ph.D. from the University of Guelph in 1979. Dr. Hollis then completed an Endocrine Fellowship at The Case Western Reserve University School of Medicine in 1982. Dr. Hollis ...

                                                                              See more See less
                                                                            • Alan Maisel, MD

                                                                              Dr. Alan Maisel attended University of Michigan Medical School and did his cardiology training at the University of California at San Diego. He is currently Professor of Medicine at the University and director of the coronary care unit and the heart failure program at the ...

                                                                              See more See less
                                                                            • Michael Holick, MD, PhD

                                                                              Michael F. Holick, Ph.D., M.D. is Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Vitamin D, Skin and Bone Research Laboratory at Boston University Medical ...

                                                                              See more See less
                                                                            • Kamisha Johnson-Davis, PhD, DABCC, FACB

                                                                              Dr. Johnson-Davis is a medical director of the Clinical Toxicology laboratory, Antifungal Testing and Immunosuppressants Testing at ARUP. Dr. Johnson-Davis received her PhD in pharmacology at the University of Utah and is board certified in clinical chemistry by the American ...

                                                                              See more See less
                                                                            • Charles Cantor, PhD

                                                                              Dr. Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc., which is a genetics discovery company with tools, information and strategies for determining the medical impact of genes and genetic variations. He is also the founder of SelectX Pharmaceuticals ...

                                                                              See more See less
                                                                            • Peter Blume-Jensen, MD, PhD

                                                                              Dr. Peter Blume-Jensen has extensive expertise in basic and translational cancer research, oncogenic signaling, and targeted oncology therapeutics drug discovery prior to joining Metamark as CSO in 2010.&nbsp; From 2001 to 2008 Peter was department head at first Serono, US and ...

                                                                              See more See less
                                                                            • Pinar Bayrak-Toydemir, MD, PhD

                                                                              Dr. Bayrak-Toydemir is the medical director of the Molecular Genetics and Genomics Laboratories at ARUP and an associate professor of pathology at the University of Utah School of Medicine. Dr. Bayrak-Toydemir received her MD from the Ankara University School of Medicine in ...

                                                                              See more See less
                                                                            • Joan W Bennett, PhD

                                                                            • Amy K Saenger, PhD, DABCC, FACB

                                                                            • Theral Timpson

                                                                            • Stephanie Willerth, PhD

                                                                              Dr. Willerth currently holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she is dually appointed in the Department of Mechanical Engineering and Division of Medical Sciences. Her research group investigates how to engineer neural tissue ...

                                                                              See more See less
                                                                            • Mark Marzinke, PhD, BABCC

                                                                              Mark Marzinke, PhD, DABCC earned a Ph.D. in Biochemistry from the University of Wisconsin-Madison and subsequently completed a clinical chemistry fellowship at The Johns Hopkins University in 2012. During his clinical fellowship, Dr. Marzinke focused on the development and ...

                                                                              See more See less
                                                                            • C Jimmy Lin, MD, PhD, MHS

                                                                              Jimmy Lin, MD, PhD, MHS, is a 2012 TED Fellow and Founder & President of Rare Genomics Institute, the world's first platform to enable any community to leverage cutting-edge biotechnology to advance understanding of any rare disease. Partnering with 18 of the top medical ...

                                                                              See more See less
                                                                            • John Quackenbush, PhD

                                                                              John Quackenbush received his PhD in 1990 in theoretical physics from UCLA working on string theory models. Following two years as a postdoctoral fellow in physics, Dr. Quackenbush applied for and received a Special Emphasis Research Career Award from the National Center for ...

                                                                              See more See less
                                                                            • Ross J Molinaro, PhD, MT(ASCP), DABCC, FACB

                                                                              Ross J. Molinaro, PhD, MT(ASCP), DABCC, FACB is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Emory University. He received his PhD in Clinical Chemistry and Molecular Medicine from Cleveland State University and completed the ComACC training ...

                                                                              See more See less
                                                                            • Wieslaw Furmaga, MD

                                                                              Director, Clinical Chemistry Laboratory University Hospital Director, General Laboratory Cancer Treatment Research Center Director, Proteomics Laboratory UTHSC at San Antonio Interim Director, Molecular Laboratory UTHSC at San Antonio Associate Director, Mycology Laboratory UTHSC ...

                                                                              See more See less
                                                                            • Andrea Rose, PhD, MBA

                                                                            • George Fritsma, MS, MT

                                                                              George Fritsma is an associate professor in Laboratory Medicine of the Department of Pathology at the University of Alabama at Birmingham. Prof. Fritsma manages www.fritsmafactor.com, "The Fritsma Factor, Your Interactive Hemostasis Resource," a clinical coagulation ...

                                                                              See more See less
                                                                            • R. Claudio Aguilar, Ph.D.

                                                                              Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...

                                                                              See more See less
                                                                            • Joely Straseski, PhD, MS, MT(ASCP), DABCC

                                                                              Dr. Straseski is a medical director of endocrinology at ARUP Laboratories and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a Master's degree in bacteriology from the University of ...

                                                                              See more See less
                                                                            • Christoph H. Borchers, Ph.D.

                                                                              Dr. Borchers received his B.S., M.S. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke - UNC Proteomics Facility and held a faculty position at UNC ...

                                                                              See more See less
                                                                            • Sharon Geaghan, MD

                                                                              Dr. Geaghan is Chief, Pathology at Lucile Packard Children's Hospital at Stanford, and Co-Director of Clinical Laboratories at Stanford Hospital and Clinics. She also directs the Bass Pediatric Cancer Center Laboratory at the Lucile Packard Hospital; is Director of the Point of ...

                                                                              See more See less
                                                                            • Vincent Mauro, Ph.D.

                                                                              Dr. Mauro is an Associate Professor in the Department of Neurobiology at the Scripps Research Institute in La Jolla, California. He is also a co-founder and lead scientist of Promosome, a biotechnology company focused on bioproduction enablement and DNA vaccines. In addition, Dr ...

                                                                              See more See less
                                                                            • Deanne Taylor, MS, PhD

                                                                              Dr. Taylors background is in biophysics, bioinformatics, computational biology and structural biology with emphasis on human genetics and translational medicine. She obtained her Ph.D. in Biophysics from the University of Michigan, Ann Arbor, and completed a postdoctoral ...

                                                                              See more See less
                                                                            • Ariel Louwrier PhD

                                                                              Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...

                                                                              See more See less
                                                                            • Pierre-Antoine Gourraud, PhD, MPH

                                                                              Pierre-Antoine Gourraud is a former student of the Ecole Normale Suprieure de Lyon in France. After receiving an M.P.H. from University Paris XIII in 2002, he got his Ph.D. in Immunogenetic Epidemiology and Public Health from Toulouse University in 2005. He relocated to the ...

                                                                              See more See less
                                                                            • Cathy Owen

                                                                            • Cynthia Bowman MD

                                                                              Dr. Cynthia Bowman has been a broad based general pathologist for over 30 years. She graduated with a BA in Chemistry from St. Olaf College, received her MD from Vanderbilt University Medical School, and trained for 6 years at the University of California, San Francisco as a ...

                                                                              See more See less
                                                                            • James H. Nichols, Ph.D., DABCC, FACB

                                                                            • Sihe Wang, PhD DABCC FACB

                                                                              Dr. Sihe Wang is Section Head and Medical Director of Clinical Biochemistry and Director of Clinical Biochemistry Fellowship Training Program, Cleveland Clinic, Cleveland, Ohio. He also chairs the clinical chemistry integration effort for the Cleveland Clinic Health System which ...

                                                                              See more See less
                                                                            • Ottavio Arancio MD, Ph.D

                                                                              Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at ...

                                                                              See more See less
                                                                            • Eric Gluck, MD, JD

                                                                            • Josip Blonder, MD

                                                                              Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...

                                                                              See more See less
                                                                            • Szczepan Baran, VMD, MS

                                                                              Dr. Szczepan Baran is the Global Head, Animal Welfare and Compliance Training at Novartis Institutes for Biomedical Research. Dr. Baran received a Bachelor of Science in Pre-Veterinary Medicine from the University of Delaware, a Veterinary Medical Doctoral degree from the ...

                                                                              See more See less
                                                                            • Agnieszka Lichanzka Ph.D.

                                                                              Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                                                              See more See less
                                                                            • Tatjana Matejic, PhD, D(ABMLI)

                                                                            • David Carpentieri, MD

                                                                            • Timothy Harris, PhD

                                                                              Since June 2011, Dr. Harris has served as the Senior Vice President of Translational Medicine at Biogen Idec. Dr. Harris has served as the Director of the Advanced Technology Program at SAIC Frederick since 2007 and Chief Technology Officer for SAIC Frederick since 2008. Prior to ...

                                                                              See more See less
                                                                            • Antonio Baines, PhD

                                                                              Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...

                                                                              See more See less
                                                                            • Daniel Irimia, MD, PhD

                                                                            • Fred Russell Kramer, PhD

                                                                            • Martin Latterich, PhD

                                                                              The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                                                                              See more See less
                                                                            • Judd Moul, MD, FACS

                                                                              Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                                                                              See more See less
                                                                            • Kathryn Wellen, PhD

                                                                            • Howard Morris, PhD, FAACB, FFSc(RCPA)

                                                                              Professor Howard Morris is Professor of Medical Sciences at the University of South Australia and a Chief Medical Scientist in Chemical Pathology at SA Pathology, Adelaide, South Australia. He is currently Vice-President of the International Federation of Clinical Chemistry ...

                                                                              See more See less
                                                                            • Alan Wright, MD

                                                                              Dr. Wright is the Chief Medical Officer at Roche Diagnostics Corporation in Indianapolis, Indiana. Prior to joining Roche, Dr. Wright served as Senior Vice President of Health Improvement Strategies for Miraca Life Sciences. He was the Vice President for Product Strategy and ...

                                                                              See more See less
                                                                            • Anthony Grace, PhD

                                                                              Dr. Anthony A. Grace is a Distinguished Professor of Neuroscience and a Professor of Psychiatry and Psychology at the University of Pittsburgh in Pittsburgh, PA. He received his Ph.D. from Yale University School of Medicine with Dr. Benjamin S. Bunney and had postdoctoral ...

                                                                              See more See less
                                                                            • Ulrich Hengst, PhD

                                                                              Dr. Ulrich Hengst studied biochemistry at the Ruhr University Bochum, Germany, and conducted his graduate research at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, in the group of Prof. Denis Monard. In 2003 he received his PhD from the ...

                                                                              See more See less
                                                                            • Paul Mathews, PhD

                                                                              Dr. Paul J. Mathews received his bachelors degree from the University of Oregon where he studied invertebrate behavioral plasticity in the lab of Dr. Nathan Tublitz. He received his Ph.D. in neuroscience from the University of Texas at Austin under the mentorship of Dr. Nace ...

                                                                              See more See less
                                                                            • Ahmad Salehi, MD, PhD

                                                                              Ahmad Salehi, M.D., Ph.D. is a Clinical Associate Professor at the Department of Psychiatry and Behavioral Sciences, Stanford Medical School and the Director of the Translational Laboratory at the VA Palo Alto Health Care System in California. He obtained his MD in Tehran, Iran ...

                                                                              See more See less
                                                                            • Katerina Venderova, PharmD, PhD

                                                                              Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western ...

                                                                              See more See less
                                                                            Help

                                                                            General LabRoots Questions

                                                                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                                                            Contact us

                                                                            Virtual Events and Webinars

                                                                            Supported Configurations

                                                                            • Operating System Internet Explorer Firefox Chrome Safari
                                                                              Vista IE8+ FF10+ Chrome15+
                                                                              Windows 7 IE8+ FF10+ Chrome15+
                                                                              Windows 8 IE10 FF10+ Chrome15+
                                                                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                                                                            • Cookie settings: session cookies enabled
                                                                            • Browser configuration must have JavaScript enabled
                                                                            • Adobe Flash player 10.2 or later

                                                                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                                                            Internet Connection

                                                                            • A minimum of 100Kbps is recommended for audio-only events
                                                                            • A minimum of 300Kbps is recommended for speaker on-video events

                                                                            Computer Equipment

                                                                            • Screen Resolution: Minimum 1024x768
                                                                            • Video Card: 65,000 colors minimum
                                                                            • Sound card and speakers (or headphones) for hearing webcast in full format
                                                                            • Audio Card: 16-bit minimum
                                                                            • RAM: 512MB of free RAM

                                                                            Firewall Protocol

                                                                            • HTTP on port 80 or HTTPS on port 443
                                                                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                                                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                                                            Work-At-Home Attendees

                                                                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                                                            For A Seamless Experience

                                                                            When using a mobile device, FREE Mobile Apps are available:

                                                                            - For viewing Webinars:

                                                                            - For viewing Virtual Events

                                                                            Attendee Guide

                                                                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                                                            Virtual Event and Webinar Support:

                                                                            Continuing Education (CME/CE) Support

                                                                            Loading Comments...
                                                                            Show Resources